NOVEL N-HYDROXYALKYL-SUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE AND PIPERIDINE DERIVATIVES
    1.
    发明申请
    NOVEL N-HYDROXYALKYL-SUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE AND PIPERIDINE DERIVATIVES 审中-公开
    新型N-羟基烷基取代的1,2,3,6-四氢吡啶和哌啶衍生物

    公开(公告)号:WO1993011107A1

    公开(公告)日:1993-06-10

    申请号:PCT/HU1992000050

    申请日:1992-12-01

    IPC分类号: C07D211/06

    摘要: The invention relates to novel N-hydroxy-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives of formula (I) wherein A stands for hydrogen or halogen; alkoxy; cyano; phenyl; phenyl monosubstituted by halogen; benzyl; benzyl monosubstituted by halogen; 2-phenylethyl monosubstituted by halogen on the phenyl moiety; or 2-picolyl group; B represents hydrogen; alkoxy or nitro group; D represents hydrogen or halogen; or alkoxy group; or B and D together stand for a -CH=CH-CH=CH- group; R represents hydrogen; alkyl or phenyl group; G is hydrogen; I stands for hydrogen or hydroxy group; or G and I together represent a single chemical bond; E stands for hydrogen or halogen; alkoxy or trifluoromethyl group; and m is 0, 1 or 2, with the proviso that: m is 0 or 2, or both G and I mean hydrogen, when A stands for benzyl or halogen-monosubstituted benzyl group; and m is 1, when A stands for 2-picolyl group, as well as their acid addition salts. The invention further relates to pharmaceutical compositions containing these compounds as active ingredients as well as to a process for the preparation of compounds of formula (I) and their intermediates. The compounds of formula (I) are useful for enhancing the tolerance of mammals (including man) against hypoxic and/or ischaemic states as well as for treating the degenerative and functional disturbances arising from hypoxic and/or ischaemic insults.

    摘要翻译: 本发明涉及式(I)的新型N-羟基取代的1,2,3,6-四氢吡啶和哌啶衍生物,其中A代表氢或卤素; 烷氧基; 氰基; 苯基; 被卤素单取代的苯基; 苄基; 被卤素单取代的苄基; 在苯基部分被卤素单取代的2-苯基乙基; 或2-吡啶甲基; B表示氢; 烷氧基或硝基; D表示氢或卤素; 或烷氧基; 或B和D一起代表-CH = CH-CH = CH-基团; R代表氢; 烷基或苯基; G是氢; 我代表氢或羟基; 或G和I一起代表单一化学键; E代表氢或卤素; 烷氧基或三氟甲基; m为0,1或2,条件是:m为0或2,或者G和I均为氢,A表示苄基或卤素 - 单取代苄基; 并且当A代表2-吡啶甲基时,m为1,以及它们的酸加成盐。 本发明还涉及含有这些化合物作为活性成分的药物组合物以及制备式(I)化合物及其中间体的方法。 式(I)化合物可用于增强哺乳动物(包括人)对缺氧和/或缺血状态的耐受性,以及用于治疗由缺氧和/或缺血损伤引起的退行性和功能障碍。

    NOVEL 14-(N-SUBSTITUTED AMINOMETHYL)EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
    2.
    发明申请
    NOVEL 14-(N-SUBSTITUTED AMINOMETHYL)EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM 审中-公开
    新型14-(N-取代氨基甲基)衍生物衍生物及其制备方法及其组合物

    公开(公告)号:WO1992010495A1

    公开(公告)日:1992-06-25

    申请号:PCT/HU1991000051

    申请日:1991-12-06

    IPC分类号: C07D461/00

    CPC分类号: C07D461/00

    摘要: The invention relates to novel, optically active cis and trans 14-(N-substituted aminomethyl)eburnane derivatives of formula (I), wherein R1 stands for hydrogen, a C1-6alkyl or C2-6alkenyl group; R2 means a C1-6alkyl, C2-6alkenyl or a hydroxy-C1-6alkyl group; or R1 and R2 represent together with the adjacent nitrogen atom to which they are attached, a 5 to 7-membered saturated ring, optionally containing one oxygen atom and/or one optionally substituted nitrogen atom as heteroatom; and n is 2 or 3, as well as pharmaceutically acceptable salts of these compounds. The compounds of the invention possess an antioxidative (lipid peroxidation-inhibiting) effect and therefore, they are useful for treating diseases connected with lipid peroxidation, such as ischaemic intestinal diseases, myocardial ischaemia, ischaemic cerebrovascular disturbances as well as some diseases of connective tissues, e.g. rheumatoid arthritis. The compounds of the invention are also suitable for treating or preventing cognitive disorders.

    摘要翻译: 本发明涉及式(I)的新型光学活性顺式和反式14-(N-取代氨基甲基)艾本烷衍生物,其中R1代表氢,C1-6烷基或C2-6烯基; R 2表示C 1-6烷基,C 2-6烯基或羟基-C 1-6烷基; 或R 1和R 2与它们所连接的相邻氮原子一起表示5至7元饱和环,任选地含有一个氧原子和/或一个任选取代的氮原子作为杂原子; 和n为2或3,以及这些化合物的药学上可接受的盐。 本发明的化合物具有抗氧化(脂质过氧化抑制)效果,因此可用于治疗与脂质过氧化相关的疾病,例如缺血性肠病,心肌缺血,缺血性脑血管障碍以及结缔组织的一些疾病, 例如 类风湿关节炎。 本发明的化合物也适用于治疗或预防认知障碍。